Scopolamine Patch, Extended Release
Product Images NDC 68071-3994

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 68071-3994). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3994 4)

Pdp (68071 3994 4)
This text appears to be a product description for a medication from NuCare Pharmaceuticals, Inc. The product is a Transdermal Patch containing Scopolamine 1mg/3 days. It is indicated to prevent nausea and vomiting. The packaging includes a warning to keep the product out of reach of children and store it at a controlled temperature of 68-77°F. The product is specifically formulated to deliver approximately 1mg of Scopolamine over 3 days. For more details, it is recommended to refer to the manufacturer's label or sales information.*
FDA Label Image

Image Description (Figure003)

FDA Label Image

Image Description (Figure01)

Image Description (Figure01)
This is a clear, disposable plastic release liner with a metallic adhesive surface and a tan backing membrane bearing an imprint of "Scopolamine 1 mg/3 days". It is likely a medication patch or transdermal system for administering Scopolamine over a three-day period.*
FDA Label Image

Image Description (Figure2)

FDA Label Image

Image Description (Figure4)

Image Description (Figure4)
This is a description of a tan-colored transdermal system with a metallic adhesive surface. The system comes with a clear, disposable plastic release liner with stippled texture. The accompanying figure (Figure 4) likely provides visual information related to the product.*
FDA Label Image

Image Description (Figure5)

Image Description (Figure5)
This is a tan-colored transdermal system imprinted with "G". It is shown in Figure 5.*
FDA Label Image

Logo (Logo01)

FDA Label Image

Logo (Logo02)

FDA Label Image

Structure (Structuralformula001)

FDA Label Image

System (System001)

System (System001)
This text describes the layers of a transdermal drug delivery system. It consists of a backing membrane, drug in adhesive layer, rate-controlling membrane, another drug in adhesive layer, and a release liner. Each layer serves a specific function in controlling the release of the drug through the skin.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.